Physician

Rohit Kapoor, M.D.

According to 2025 Medicare claims, Rohit Kapoor, M.D. (NPI: 1750392908) practices hematology/oncology in the San Antonio-New Braunfels, TX market, with the plurality of this provider's patient population coming from Guadalupe, TX. This provider's primary affiliated billing organization is ROHIT KAPOOR MD PA (NPI: 1790805877; TIN: 742980813) and primary practice location at 78233-3270. Kapoor is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Kapoor's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 688 traditional Medicare patients, billed 90,665 HCPCS/CPT codes, and received $2,065,678 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,316 prescription claims across 286 beneficiaries totaling $10,776,221 in drug costs, led by Padcev (Enfortumab Vedotin-Ejfv). DME data shows 39 claims. Open Payments data shows 207 records totaling $12,058. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,658,075 to $10,776,221. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $14,279 to $1,490.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	886	163,698	$2,027,475
2016	856	147,495	$1,870,458
2017	867	170,965	$2,635,488
2018	811	209,241	$2,578,463
2019	710	124,575	$2,702,373
2020	655	126,198	$2,480,794
2021	692	87,554	$1,865,106
2022	715	105,129	$2,084,221
2023	660	121,004	$2,227,675
2024	688	90,665	$2,065,678

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	188	1,872	$2,658,075
2016	200	2,090	$3,973,366
2017	209	1,923	$3,352,174
2018	189	1,833	$3,574,909
2019	213	1,809	$4,336,950
2020	206	2,020	$5,793,305
2021	227	2,138	$6,556,330
2022	255	2,076	$6,832,108
2023	278	2,070	$7,962,360
2024	286	2,316	$10,776,221

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	24	203	$118,479
2016	N/R	141	$117,131
2017	N/R	59	$90,217
2018	N/R	28	$4,224
2019	N/R	N/R	N/R
2020	N/R	36	$33,319
2021	N/R	61	$40,778
2022	N/R	65	$40,866
2023	N/R	47	$41,770
2024	N/R	39	$43,587

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	303	604	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	442	1,284	$62
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	433	1,068	$12
36415	Insertion of needle into vein for collection of blood sample	544	2,526	$9
85027	Complete blood cell count (red cells, white blood cell, platelets), automated test	536	2,447	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Padcev	Enfortumab Vedotin-Ejfv	52	1,092	$1,700,487
Keytruda	Pembrolizumab	141	2,961	$1,682,824
Opdivo	Nivolumab	59	1,519	$812,973
Imbruvica	Ibrutinib	30	840	$475,036
Neulasta	Pegfilgrastim	47	1,127	$439,896

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	13	$42,454
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	13	$1,000
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	13	$134

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	206	$11,308	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$750	BioNTech SE
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rohit Kapoor, M.D.?

Tedicare shows public-source Medicare data for Rohit Kapoor, M.D. (NPI 1750392908), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rohit Kapoor, M.D. have ACO affiliation data?

Rohit Kapoor, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Rohit Kapoor, M.D.?

Rohit Kapoor, M.D. is linked to ROHIT KAPOOR MD PA (billing NPI 1790805877) in the available physician profile data.

Does Rohit Kapoor, M.D. have Open Payments data?

Rohit Kapoor, M.D. has 207 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.